alexa Total Elbow Arthroplasty Following Septic Arthritis with Staphylococcus aureus: A Case Report and Review of the Literature | Open Access Journals
ISSN: 2165-7920
Journal of Clinical Case Reports
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Total Elbow Arthroplasty Following Septic Arthritis with Staphylococcus aureus: A Case Report and Review of the Literature

Markus Rupp*, Joerg Mika, Christoph Biehl, Christian Heiss and Volker Alt

Department of Trauma-, Hand- and Reconstructive Surgery, Justus Liebig University Giessen, University Hospital Giessen and Marburg, Campus Giessen, Germany

*Corresponding Author:
Markus Rupp
Department of Trauma-, Hand- and Reconstructive Surgery
Justus Liebig University Giessen, University Hospital Giessen and Marburg
Campus Giessen
Germany
Tel: +49641 990
E-mail: Markus.Rupp@chiru.med.uni-giessen.de

Received date: March 02, 2017; Accepted date: May 25, 2017; Published date: May 30, 2017

Citation: Rupp M, Mika J, Biehl C, Heiss C, Alt V (2017) Total Elbow Arthroplasty Following Septic Arthritis with Staphylococcus aureus: A Case Report and Review of the Literature. J Clin Case Rep 7: 961. doi: 10.4172/2165-7920.1000961

Copyright: ©2017 Rupp M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Clinical Case Reports

Abstract

Septic arthritis of the elbow seems to be a contraindication for total elbow arthroplasty (TEA). We here describe a 65-year-old male, American Society of Anesthesiologists (ASA) class 3-patient, with a severely destructed right elbow due to septic arthritis with Staphylococcus aureus. His treatment consisted of multiple irrigation and debridement procedures including resection of the distal humerus, soft tissue coverage by local rotational flap and the use of a gentamicin-vancomycin loaded PMMA spacer, i.v. and oral antibiotics. After eradication of infection, a constraint cemented TEA could then successfully be performed eight months after the initial surgery and twenty-five weeks after the last debridement procedure. Twenty-one months after the TEA, the patient remained infect free and shows excellent functional results: Disabilities of the Arm, Shoulder and Hand (DASH) score: 38.3, Broberg and Morrey score: 91/100, Mayo elbow score: 95/100. To the best of our knowledge this is the first case in the literature that demonstrates TEA after septic elbow arthritis with S. aureus. Although TEA is known as a typical surgical procedure with a low volume in numbers and higher complication rates, such as elevated infection rates compared to other types of arthroplasty, septic arthritis with S. aureus can successfully be performed after eradication of the infection and targeted antibiotic therapy.

Keywords

Septic arthritis; Arthroplasty; Staphylococcus aureus; Surgery

Introduction

Compared to the hip and knee, total elbow arthroplasty (TEA) is a rare surgical procedure. Its annual incidence is 1.4 per 100,000 compared to incidence rates of total hip replacement as 70 to 99 in 100,000 of the population [1,2]. In other words: 3136 TEAs within 5 years vs. about 700,000 total knee arthroplasties annually in the United States describe the low volume in numbers of TEA [3]. Unlike in hip and knee arthroplasty primary osteoarthritis is not the main indication for total elbow arthroplasty. Because of better medical treatment for rheumatoid arthritis due to the improved medical management with disease-modifying antirheumatic drugs, the number of annually performed TEAs decreases in patients suffering from rheumatoid arthritis. Nowadays posttraumatic sequelae with posttraumatic osteoarthritis after complex elbow fractures are the main reason for TEA and lead to an overall increase in numbers [4,5]. Further indications for elbow arthroplasty are distal humerus non-unions, primary osteoarthritis, haemophilic arthropathies and reconstruction after tumor resection [6,7].

Complication rates regarding TEA are much higher compared to frequently performed total hip and knee arthroplasty. A complication rate in TEA up to 43% was described in 1996 [8]. Although advances in prosthetic design and surgical techniques have been made since the 1990´s the complication rates remain high. A surgical revision rate of 69% for any reason within 5 years after TEA has been reported for patients with rheumatoid arthritis [9]. Toulemonde et al. showed a complication rate of 37% at a 5-year follow-up average [10]. Typical complications of TEA are ulnar neuropathy and weakness of the triceps muscle. In addition, periprosthetic joint infections play a major role as a reason for revision surgery in TEA. The incidence of elbow periprosthetic joint infection is reported to be in the range 3% to 11% compared to an overall incidence range of 2% to 2.4% in hip and knee arthroplasty [11,12]. Within this framework, avoidance of TEA after septic arthritis seems to be a wise surgical decision. However, alternatives like salvage procedures such as resection arthroplasty or elbow arthrodesis (EA) are accompanied either with instability combined with loss of strength or loss of motion in case of an arthrodesis.

Here we demonstrate a case of a patient suffering from septic arthritis with , with relevant comorbidities, such as diabetes mellitus type 2, successfully treated with TEA after eradication treatment of the infection.

Case Report

A 65-year-old man presented with a swollen, red and painful right elbow in our emergency room. The ASA class 3-patient suffered from diabetes mellitus type 2, obesity, congestive heart failure, coronary artery disease, atrial fibrillation, hereditary factor VIII deficiency and von Willebrand´s disease. Clinical examination showed purulent discharge above the bursa olecrani. Due to enormous pain, the patient was not able to move his elbow. X-rays of the elbow revealed severe destruction of the elbow joint with calcification of the surrounding soft tissue (Figure 1). Septic arthritis of the elbow joint was diagnosed, and an excision of the fistula, total synovectomy, extensive surgical debridement, irrigation with polyhexanide, insertion of gentamicin-polymethyl metacrylate beads and an immobilization of the elbow joint by insertion of an external fixation device was performed. Calculated intravenous antibiotic therapy was started with Unacid® 3 g (2 g Ampicillin, 1 g Sulbactam) three times a day. The microbiological isolation of Staphylococcus aureus from tissue samples obtained during surgery confirmed the septic elbow arthritis. The histological description of a fibrinous-purulent synovialitis matched the clinical aspect of the putrid joint infection. Throughout the following treatment, a total of 8 surgical revisions were necessary within 66 days. Due to enormous swelling, of the elbow after initial surgery a temporary skin replacement using a polyvinyl acetate sponge (Coldex®, Velo Medizinprodukte GmbH, Sengenthal, Germany) was applied during the first revision surgery. Irrigation with polyhexanide, jet lavage and surgical debridement of the elbow joint including resection of infected bone was performed each time. Furthermore, local drug carriers with gentamicin as a local antibiotic as well as further skin replacement sponges were exchanged on a regular base. Soft tissue coverage was achieved at the medial aspect of the elbow joint by local flap and eradication of the infection could be achieved. Following temporary arthrodesis with an external fixator, a cemented constraint elbow prosthesis (Discovery®, Zimmer Biomet, Warsaw, Indiana, USA) was implanted eight weeks after the initial surgery and twenty-five weeks after the last debridement procedure. After implantation of the elbow prosthesis antibiotic therapy was perioperatively started with cefazolin 2 g three times a day and rifampicin 300 mg twice a day. After administration of those intravenous antibiotics for 1 week, the therapy was switched to oral antibiotics using ciprofloxacin 500 mg twice a day and rifampicin 300 mg twice a day for 4 weeks as prolonged antibiotic therapy to avoid a biofilm. With the above described therapy the wound healing showed no abnormalities.

clinical-case-reports-destructive-elbow

Figure 1: Preoperative X-rays of destructive elbow joint arthritis in lateral (A) and anterior-posterior (B) projection.

Eight weeks after TEA the patient had to be readmitted with a wound dehiscence requiring surgical revision. Fortunately, just a superficial wound dehiscence was found without an involvement of the deeper soft tissue layers or of the prosthesis and the wound could be closed after skin debridement.

Twenty-one months after implantation of the Discovery® elbow prosthesis the patient remained infection-free. Patient based scores such as the DASH [13], Broberg and Morrey score [14] as well as the Mayo elbow score [15] showed excellent results. The clinical examination showed irritation free scars without any neurovascular irregularities of the arm. Sensation of the arm was entirely intact except of the area in direct vicinity to the former incision. The range of motion of the elbow was extension/flexion 0-20-100° (Figures 2-4), pronation/supination 90-0-70°. There was neither subjective nor objective joint instability. The patient mentioned a mild loss of strength in his forearm compared to the other side. The following scores were found: Mayo elbow score 95/100 points, Broberg and Morrey score 91/100 points, DASH score 38.3 points. X-rays showed the TEA without any radiological signs of implant loosening after 2 months (Figure 2) and 21 months, respectively (Figures 3 and 4). Signs of a non-union of the olecranon tip were visible.

clinical-case-reports-elbow-prosthesis

Figure 2: Postoperative X-rays of the elbow prosthesis. 2 months after implantation no radiological sign of loosening is detectable in anterior-posterior (A) and lateral (B) projection, signs of a dislocation of the olecranon were visible, though.

clinical-case-reports-radiological-sign

Figure 3: Postoperative X-rays of the elbow prosthesis 21 months after implantation. No radiological sign of loosening is detectable in anterior-posterior (A) and lateral (B) projection. Unchanged signs of non-union development at the olecranon tip.

clinical-case-reports-right-elbow

Figure 4: Flexion (A) and extension (B) of the right elbow 21 months after TEA.

Discussion

Septic arthritis was diagnosed due to clinical and radiological findings. Purulent discharge and clinical signs of local infection lead to the early diagnosis using criterias described by Newman (Table 1) [16]. Mortality in patients suffering from monoarticular sepsis seems to be around 11% [17], permanent joint damage is reported in up to 50% [18]. Hence, early revision surgery combined with antibiotic therapy was carried out immediately.

a Organism isolated from the joint
b Organism isolated from elsewherein context of a swollen and warm joint
c Histological and radiological evidenceof infection
d Turbid fluid aspiration in context of a possible joint infection

Table 1: Criteria for diagnosis of septic arthritis [16].

Gächter classified septic arthritis in a four-stage manner (Table 2) [19]. Based on this classification a stage dependent treatment of septic arthritis was established [20]. If Gächter type I-III septic arthtitis is treated by arthroscopic irrigation, debridement and antibiotic therapy, cartilage and joint preserving therapy is intended. Unfortunately, antiseptics such as polyhexanide, hydrogen peroxide and taurolidin have besides their broad antimicrobial range and high potential for defeating infections in septic surgery an apoptosis inducing effect in chondrocytes [21]. Therefore, use of antiseptics in joint preserving therapy is not recommended [20]. The lack of antiseptics without cartilage damaging effects, might be one reason for the reported permanent joint damage up to 50%. However, the reason for high morbidity and mortality rates might be infection with Staphylococcus aureus itself. Independent of age, path of infection and other risk constellations Staphylococcus aureus is the most common bacterium in septic arthtitis [18]. Moreover, Staphylococcus aureus is characterized by certain surface proteins (protein A, collagen adhesion (Cna), clumping factor (ClfA), which can explain joint affinity. High morbidity and mortality are attributed to such virulence factors [22].

Stage I Turbid synovia, inflammatory redness of thesynovial membrane, possible petechial haemorrhage no radiological changes
Stage II Severe inflammation with fibrin deposits, pus no radiological changes
Stage III                Thickening of the synovial membrane, articularcompartment formation, still no radiological changes
Stage IV                Extensive pannus formation, radiologicallydetectable subchondral osteolysis, bony erosionsand cysts formation

Table 2: Gächter classification of septic arthritis [19].

Because of clinical signs of infection and radiological signs of joint destruction of a Gächter stage IV septic arthritis, open revision surgery was necessary in our case. Radiological evidence of joint destruction indicated surgical therapy. Complying with principles of septic surgery in a curative approach, radical debridement, soft tissue coverage and reconstruction as well as immobilisation through temporary arthrodesis combined with local and systemic antibiotic therapy was carried out [23]. Antibiotic anti-biofilm therapy was administered as described for endoprosthesis reimplantation after periprosthetic joint infections with antibiotic sensitive Staphylococcus aureus [24] (Table 2).

After infect eradication three orthopaedic treatment principlesarthroplasty, arthrodesis and resection arthroplasty-were left over as surgical treatment opportunities.

Due to the high prevalence of postoperative complications in TEA, septic arthritis of an elbow joint seems to be a contraindication for TEA [25]. In the literature, several studies show good outcomes after TEA in primary and revision elbow arthroplasty [10,26]. However, comparison of the published data is difficult due to many reasons: different indications for TEA, different kind of elbow prosthesis, different follow-up periods, different end points, different scoring systems. Nevertheless, the result of our 21 months follow-up with a very satisfied, pain free patient as well as good clinical results and scores is consistent with a high satisfaction rate of 90%, an increase in pain free patients from 7% to 63% and an improved range of motion up to an extension-flexion-arc of 93° and a supination-pronation-arc of 113° in a prospective clinical outcome study regarding the Discovery® elbow prosthesis for different indications [27]. Mid-term outcome of TEA in 21 patients suffering from rheumatoid arthritis after a mean follow-up of 64 months are similar. The mean DASH score improved after TEA from 72.3 to 46.8, mean flexion from 96.9° to 128.1°, mean extension lag from 37.3° to 24°, but it has to be taken in account that patients were not infected and without previous surgeries [9].

The satisfying outcome after TEA was not compromised by the patient´s complex medical condition. Concerning risk factors for TEA progressed diabetes mellitus, obesity and male sex were proven as such [28-30].

If surgeons assess the risk of a TEA as too high, other options for the patients have to be reflected. EA as a salvage procedure after infection of periprosthetic elbow infections have also a high complication rate and often no confirmed union [31]. Furthermore, the trade-off for functional activity and pain relief is loss of motion, which cannot be compensated by shoulder and wrist joints [32]. Though, conversions of EA to TEA are reported showing a good clinical outcome even after EA for 7 and 30 years, respectively [33,34]. Concerning septic surgical principles this is an interesting finding. Immobilisation of the joint is a key principle for elimination of infections. As demonstrated, 8 months of temporary EA using an external fixation device was no obstacle rather than an important tool for the satisfying outcome at the 21 months follow-up.

Resection arthroplasty of the elbow should be mentioned as a further salvage procedure. Mostly fair and poor results with a high complication rate, leave resection arthroplasty a salvage option in patients with refractory infection and failed other surgical treatment options [35]. Therefore, it was not regarded as a therapy option in our patient.

Conclusion

Despite the obstacles including destructive arthritis with Staphylococcus aureus of the right elbow and relevant comorbidities, such as diabetes mellitus type II, TEA was feasible by respecting septic surgery and antibiotic treatment principles consisting of eradication of the infection before implementation of the prosthesis, and the use of antibiofilm antibiotics.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

  • Global Experts meeting on Oncology Case Reports
    Aug 29-31, 2017 London, UK
  • Global Experts Meeting on Case Reports
    Osaka, Japan October 09-11, 2017
  • 6th Global Experts Meeting on Medical Case Reports
    October 16-18, 2017 San Francisco, California, USA

Article Usage

  • Total views: 228
  • [From(publication date):
    May-2017 - Jul 28, 2017]
  • Breakdown by view type
  • HTML page views : 200
  • PDF downloads :28
 
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsonline.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsonline.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsonline.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsonline.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsonline.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsonline.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsonline.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsonline.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsonline.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsonline.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsonline.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsonline.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsonline.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsonline.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsonline.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsonline.com

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version